News

Exact Sciences Corp.? has released new performance data for its blood-based colorectal cancer (CRC) screening test. The results indicate an 88.3% sensitivity for CRC and 31.2% for advanced precancerous lesions,

Read more...

Synchron, a leading brain-computer interface (BCI) company, has achieved a notable milestone with the first use of Amazon?s Alexa by a patient implanted with Synchron?s BCI technology. Mark, a 64-year-old man with amyotrophic lateral sclerosis

Read more...

Remedee Labs, a French start-up focused on non-pharmacological treatments for chronic pain, has announced that its millimeter wave endorphin stimulator wristband has officially been granted medical device status in Europe.

Read more...

King Faisal Specialist Hospital & Research Centre recently achieved a major medical milestone by performing the world?s first fully robotic heart transplant on a 16-year-old patient with end-stage heart failure.

Read more...

Neuraptive Therapeutics has announced that its investigational drug, NTX-001, has been granted Breakthrough Therapy Designation by the FDA. This designation could significantly speed up the development process for this therapy

Read more...

Alio, Inc., a leader in AI-powered clinical-grade wearables, has announced an international study aimed at extending its technology beyond the dialysis field. The CAVA protocol will evaluate Alio?s FDA-cleared SmartPatch technology

Read more...

Proprio, a leading innovator in AI-powered surgical technology, has achieved a significant milestone with its cutting-edge surgical guidance platform, Paradigm, completing 50 successful surgeries.

Read more...

Signet Healthcare Partners ("Signet") is pleased to announce that Paragonix Technologies ("Paragonix" or the "Company"), a leader in organ transplantation and preservation technology,

Read more...

IR-MED, a developer of non-invasive, AI-driven spectrographic technology, has launched an evaluation of its PressureSafe? device at Methodist Healthcare in San Antonio, Texas.

Read more...

Bearpac Medical, LLC has launched the AESOP clinical trial, which stands for Assessing Experience, Safety, and Outcomes of the Passio Pump Drainage System. This single-center, crossover, non-blinded

Read more...